Primary Site >> Pancreatic Cancer

Gene >> ATR

Journal: Clin Cancer Res. 2008 Apr 1;14(7):2042-8.
Title: Single-nucleotide polymorphisms of DNA damage response genes are associated with overall survival in patients with pancreatic cancer.
Author: Okazaki, Taro|Jiao, Li|Chang, Ping|Evans, Douglas B|Abbruzzese, James L|Li, Donghui
PMID: 18381943
Journal: Cancer Res. 2010 Jun 15;70(12):4972-81.
Title: Mechanism of radiosensitization by the Chk1/2 inhibitor AZD7762 involves abrogation of the G2 checkpoint and inhibition of homologous recombinational DNA repair.
Author: Morgan, Meredith A|Parsels, Leslie A|Zhao, Lili|Parsels, Joshua D|Davis, Mary A|Hassan, Maria C|Arumugarajah, Sankari|Hylander-Gans, Linda|Morosini, Deborah|Simeone, Diane M|Canman, Christine E|Normolle, Daniel P|Zabludoff, Sonya D|Maybaum, Jonathan|Lawre
PMID: 20501833
Journal: Nat Struct Mol Biol. 2011 Nov 27;18(12):1331-5.
Title: Exploiting oncogene-induced replicative stress for the selective killing of Myc-driven tumors.
Author: Murga, Matilde|Campaner, Stefano|Lopez-Contreras, Andres J|Toledo, Luis I|Soria, Rebeca|Montana, Maria F|D'Artista, Luana|Schleker, Thomas|Guerra, Carmen|Garcia, Elena|Barbacid, Mariano|Hidalgo, Manuel|Amati, Bruno|Fernandez-Capetillo, Oscar
PMID: 22120667
Journal: Cancer Biol Ther. 2012 Sep;13(11):1072-81.
Title: The novel ATR inhibitor VE-821 increases sensitivity of pancreatic cancer cells to radiation and chemotherapy.
Author: Prevo, Remko|Fokas, Emmanouil|Reaper, Philip M|Charlton, Peter A|Pollard, John R|McKenna, W Gillies|Muschel, Ruth J|Brunner, Thomas B
PMID: 22825331
Journal: Cell Death Dis. 2012 Dec 6;3:e441.
Title: Targeting ATR in vivo using the novel inhibitor VE-822 results in selective sensitization of pancreatic tumors to radiation.
Author: Fokas, E|Prevo, R|Pollard, J R|Reaper, P M|Charlton, P A|Cornelissen, B|Vallis, K A|Hammond, E M|Olcina, M M|Gillies McKenna, W|Muschel, R J|Brunner, T B
PMID: 23222511
Journal: Oncotarget. 2015 May 30;6(15):13072-87.
Title: Wee1 is required to sustain ATR/Chk1 signaling upon replicative stress.
Author: Saini, Priyanka|Li, Yizhu|Dobbelstein, Matthias
PMID: 25965828
Journal: Cell Rep. 2016 Jun 28;16(1):133-147.
Title: In Vivo Functional Platform Targeting Patient-Derived Xenografts Identifies WDR5-Myc Association as a Critical Determinant of Pancreatic Cancer.
Author: Carugo, Alessandro|Genovese, Giannicola|Seth, Sahil|Nezi, Luigi|Rose, Johnathon Lynn|Bossi, Daniela|Cicalese, Angelo|Shah, Parantu Krushnakant|Viale, Andrea|Pettazzoni, Piergiorgio Francesco|Akdemir, Kadir Caner|Bristow, Christopher Aaron|Robinson, Freder
PMID: 27320920
Journal: J Biol Chem. 2016 Oct 14;291(42):21956-21962.
Title: Ewing Tumor-associated Antigen 1 Interacts with Replication Protein A to Promote Restart of Stalled Replication Forks.
Author: Feng, Sumin|Zhao, Yichao|Xu, Yixi|Ning, Shaokai|Huo, Wei|Hou, Mei|Gao, Ge|Ji, Jianguo|Guo, Rong|Xu, Dongyi
PMID: 27601467
Journal: World J Gastroenterol. 2016 Aug 28;22(32):7275-88.
Title: Perspectives on the combination of radiotherapy and targeted therapy with DNA repair inhibitors in the treatment of pancreatic cancer.
Author: Yang, Shih-Hung|Kuo, Ting-Chun|Wu, Hsu|Guo, Jhe-Cyuan|Hsu, Chiun|Hsu, Chih-Hung|Tien, Yu-Wen|Yeh, Kun-Huei|Cheng, Ann-Lii|Kuo, Sung-Hsin
PMID: 27621574
Journal: Oncol Rep. 2017 Jun;37(6):3377-3386.
Title: Inhibition of ATR potentiates the cytotoxic effect of gemcitabine on pancreatic cancer cells through enhancement of DNA damage and abrogation of ribonucleotide reductase induction by gemcitabine.
Author: Liu, Shuang|Ge, Yubin|Wang, Tingting|Edwards, Holly|Ren, Qihang|Jiang, Yiqun|Quan, Chengshi|Wang, Guan
PMID: 28440428
Journal: PLoS One. 2017 May 30;12(5):e0178221.
Title: The G2 checkpoint inhibitor CBP-93872 increases the sensitivity of colorectal and pancreatic cancer cells to chemotherapy.
Author: Iwata, Tsutomu|Uchino, Tairin|Koyama, Ayako|Johmura, Yoshikazu|Koyama, Kenichi|Saito, Takuya|Ishiguro, Seiji|Arikawa, Takashi|Komatsu, Shunichiro|Miyachi, Masahiko|Sano, Tsuyoshi|Nakanishi, Makoto|Shimada, Midori
PMID: 28558031
Journal: Int J Mol Sci. 2017 Aug 31;18(9). pii: ijms18091886.
Title: The Role of PALB2 in the DNA Damage Response and Cancer Predisposition.
Author: Nepomuceno, Thales C|De Gregoriis, Giuliana|de Oliveira, Francisco M Bastos|Suarez-Kurtz, Guilherme|Monteiro, Alvaro N|Carvalho, Marcelo A
PMID: 28858227
Journal: Biomed Pharmacother. 2018 Jan;97:1250-1258.
Title: Vildagliptin loaded triangular DNA nanospheres coated with eudragit for oral delivery and better glycemic control in type 2 diabetes mellitus.
Author: Baig, Mirza Muhammad Faran Ashraf|Khan, Sara|Naeem, Muhammad Ahsan|Khan, Ghulam Jilany|Ansari, Muhammad Tayyab
PMID: 29145151
Journal: Oncol Lett. 2018 Jun;15(6):8878-8884.
Title: 3F-Box protein 32 degrades ataxia telangiectasia and Rad3-related and regulates DNA damage response induced by gemcitabine in pancreatic cancer.
Author: Yang, Chong|Fan, Ping|Zhu, Shikai|Yang, Hongji|Jin, Xin|Wu, Heshui
PMID: 29805624